Novo Nordisk Starts Phase I Trial With Long-Acting Oral GLP-1 Analogue

Podiatry Arena Novo Nordisk Starts Phase I Trial With Long-Acting Oral GLP-1 Analogue

Welcome to the Podiatry Arena forums, for communication between foot health professionals about podiatry and related topics.

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members (PM), upload content, view attachments, receive a weekly email update of new discussions, earn CPD points and access many other special features. Registered users do not get displayed the advertisments in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

If you have any problems with the registration process or your account login, please contact contact us.

Novo Nordisk Starts Phase I Trial With Long-Acting Oral GLP-1 Analogue

Submit Thread >

< Submit Thread

Thread Tools

Display Modes

13th January 2010, 09:20 PM

RSSFeedBot RSSFeedBot is offline

I, Robot

About:

Join Date: Jul 2008

Posts: 10,128

Join Date: Jul 2008

Marketplace reputation 0% (0)

CPD Points: 1

Thanks: 0

Thanked 22 Times in 22 Posts

Novo Nordisk Starts Phase I Trial With Long-Acting Oral GLP-1 Analogue

Podiatry Arena members do not see these ads

Emisphere Technologies, Inc. today announced that Novo Nordisk has initiated its first Phase I clinical trial with a long-acting oral GLP-1 analogue (NN9924). This milestone releases a $2 million payment to Emisphere, whose proprietary Eligen® Technology is used in the formulation of NN9924. GLP-1 (Glucagon-Like Peptide-1) is a natural hormone involved in controlling blood sugar levels...

More...

Sponsored Links

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts	vB code is On Smilies are On [IMG] code is On HTML code is On

Forum Jump

Translate This Page

Similar Threads

Thread	Thread Starter	Forum	Replies	Last Post
Adeona Announces Publication Of Results Of 160 Patient Phase 2 Clinical Trial Of Oral DnaJP1 For Rheumatoid Arthritis	RSSFeedBot	Latest Rheumatology News	0	15th November 2009 06:10 AM
Novo Nordisk Announces Upcoming Launch Of NovoPen Echo(TM), A Unique New Insulin Pen For Children With Diabetes	RSSFeedBot	Latest Diabetes Medicine Research & News	0	22nd October 2009 10:20 AM
Updated Data From Randomized Controlled Phase II Study Evaluating Oral Apremilast In Psoriatic Arthritis Demonstrates Sustained Response At Six Months	RSSFeedBot	Latest Rheumatology News	0	21st October 2009 02:40 AM
BioCis Pharma Starts Phase IIa Trial In Psoriasis	RSSFeedBot	Latest Dermatology News	0	13th March 2009 05:51 AM
CPEX Pharmaceuticals Initiates Phase II Clinical Trial Of Nasulin(R)	RSSFeedBot	Latest Diabetes Medicine Research & News	0	26th February 2009 11:30 AM

New To Site?	Need Help?
Register to Participate View Forum Leaders Contact Us	Frequently Asked Questions Did you forget your password? Mark Forums Read

Finding your way around:

Browse the forums.

Search the site.

Browse the tags.

Search the tags.

All times are GMT -7. The time now is 02:25 PM.

User Name		Remember Me?
Password